BioTech firm Nuclera has appointed a new non-executive chairman in Dr Jonathan Milner. The Cambridge company is a pioneer in rapid protein prototyping through its eProtein Discovery benchtop system.  The firm’s technology aims to accelerate breakthrough improvements in human health by enabling pharmaceutical companies to rapidly produce high-quality, soluble and active proteins.  Nuclera is also … Continue reading BioTech titan joins Cambridge startup Nuclera